CLINICAL_TRIALS
withdrawal
· 2024-04-18
Clinical Trial Update: SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery [Phase 3]
Summary
A Phase 3 trial assessing aspirin versus standard of care for VTE prophylaxis after IBD surgery has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stefan Holubar MD MS FACS, FASCRS | Conditions: Crohn Disease, Ulcerative Colitis | Phase 3 | Status: WITHDRAWN